June 8-9, 2015 - Nice, France


Get Adobe Flash player

Tuesday June 9
08.15   Carotid Occlusive Disease
Are we ready for the next breakthrough?
    Moderators: M. Amor, P. Schneider, K. Snyder, L. Inglese
    08.15   State-of-the-art: promising next steps, K. Mathias
    08.30   What the data is telling us: the first 30 days need to be safer after any carotid repair, but how?, C. Setacci
    08.38   New stent designs: will they improve results? P. Schneider
    08.46   New access technologies, N. Cheshire
        08.54 Best medical therapy has improved: but how much, and will BMT be
good enough to replace repair?, I. Van Herzeele
        08.59 Carotid endarterectomy remains the treatment of choice. The data
prove it and stents cannot compete, A. Mansilha
        09.04 Discussion
    09.09   What is the optimal approach to asymptomatic carotid stenosis?
Intervention or not? We cannot all be correct! A. Halliday
    09.17   Challenging case: the worst complication of the year.
Can you help me problem solve? M. Amor
    09.25   Emergency management system: how to handle evolving stroke, K. Mathias
    09.33   Selection of stent and protection technique: which stent for which lesion,
M. Amor
    09.41   Mechanical thrombectomy for acute stroke, K. Snyder
    09.52   Discussion
    10.00   Coffee break in the exhibition hall
    10.30   Results from the ROADSTER Trial and EU Experience, I. Van Herzeele
    10.38   CAS revival is now, P. Bergeron
    10.46   Get organized for in Hospital stroke (jatrogenic or not) acute rescue, L. Inglese
    10.54   Discussion
    11.00   How I see the future of CAS, F. Veith
11.15   Femoropopliteal disease - Part 2
    Moderators: Y. Gouëffic, K. Deloose, P. Schneider, C. Setacci
    TASC C/D femoropopliteal lesions
    11.15   Heparin bounded graft could challenge endovascular repair for TASC C-D lesions? R. Pulli
    11.23   Intra versus subintimal routes to treat femoropopliteal CTO lesions: techniques and results, F. Thaveau
    11.31   Endovascular treatment of occluded popliteal artery aneurysm, P. Veroux
    11.39   Discussion
    Managing complications
    11.45   How should we manage acute in-stent thrombosis during femoropopliteal
recanalisation? Y. Gouëffic
    11.53   Recurring in-stent restenosis: what is the best management? E. Ducasse
    12.01   Acute popliteal endograft occlusion: frequency and management,
E. Puras Mallagray
    12.09   Panel discussion
12.15   Moving toward Drug Eluting Solutions
    Moderator: M. Amor
    12.15   Clinical results Majestic trial, K. Keirse
    12.35   Experience of drug eluting technologies, M. Sibé
    13.00   Buffet lunch served on the rooftop, coffee served in the exhibition hall
14.00   The A-Z of A-I disease
    Moderators: R. McWilliams, I. Van Herzeele
    14.00   How I do PEVAR? – Video, Z. Rancic
    14.08   Overlay and dose reduction during aortic procedures, J. Constantinou
    14.16   Will EVAS replace EVAR? I. Loftus
    14.24   EVAS and EVAR: What are the differences in case selection, deployment and
surveillance? F. Torella
    14.32   Single sided access for EVAR: the future, M. Lachat
    14.40   Review of the literature on type II endoleaks, R. McWilliams
    14.48   Late endoleak management – case discussions – MCQ’s, J. Van Den Berg
    14.56   State of the art – How I do FEVAR? P. Kasprzak
    15.04   Troubleshooting after FEVAR, R. Vallabhaneni
    15.12   Iliac branched devices versus Iliac branched endoprothesis – differences in selection and usage, F. Verzini
    15.20   The lessons I have learned from RCT on RAAA management, F. Veith
    15.28   New evidences for hypogastric artery preservation during EVAR,
E. Jean-Baptiste
    15.36   Tips and tricks for the CERAB technique, K. Deloose
    15.44   Is the endovascular world ready for 3D-printing and... vice versa? L. Maene
    15.50   Discussion
16.00   Associate Faculty and trainees program
From start to excellency
    Jury: N. Cheshire, P. Bergeron
    Oral presentations in the auditorium
    Jury: N. Mangialardi, E. Ducasse
    ePosters presentations in the exhibition hall
    Oral presentations in the auditorium
    • Long-term performance of closed cell design self-expanding stainless steel stents in the treatment of Cockett’s Syndrome, Luis Loureiro
    • Loss of kidney function after endovascular treatment of peripheral arterial disease,
Lars Bolt
    • Novel Innovative Endovascular Technique to salvage acute limb ischemia in Hostile Groin, Virendersingh Sheorain
    • Management of long Flush Superficial Femoral Artery Occlusions with Ipsilateral antegrade common femoral artery access, Amr Aborahma
    • Percutaneous imaging guided techniques of PV patency and integrity management - catheter directed local thrombolysis, stenting, endoluminal RFA & angioplasty or endoluminal RFA & stenting, Malkhaz Mizandari
    • Neurocognitive Functioning After Carotid Endarterectomy and Carotid Stenting With Filter Protection or Flow Reversal, Maarten Plessers
    • Mid-term outcome of hybrid revascularisation procedures for TASC C and D aorto-iliac and femoropopliteal disease, Vassilios Zymvragoudakis
    • What is the best Solution for In-Stent Restenosis after SFA Stenting: redo-PTA by use of POBA, Drugcoated balloons or Stent-Grafts, Koen Keirse
    • Adjunctive Procedures to lower risks of neurovascular complications in Thoracic Endovascular Aortic Repair: Experience in The Oxford Regional Vascular Unit,
Francesca Fratesi
    • Thrombosis of femoral-popliteal graft treated with ultrasound assisted catheter – directed thrombolysis and stenting, Cinzia Moncalvo
    • Abdominal Aortic Aneurysm Repair Increases Cardiovascular Risk, Vimal Gokani
    • Does reintervention influence the late results of EVAR? Diletta Loschi
    • Early outcomes of patients transferred with ruptured suprarenal aneurysm or dissection: implications for the organisation of vascular services, Nung Rudarakanchana
    • OffRoad™ Re-entry Catheter System for Subintimal Recanalization of Chronic Total Occlusions in Femoropopliteal Arteries: Primary Safety and Efficacy Results of the Re-ROUTE Trial, Koen Keirse
    • Percutaneous recanalization of occluded renal arteries in patient with resistant hypertension and high rennin activity, Ivo Petrov
    • Vertebral stenting, Iveta Tasheva
    • Intervention for acute lower limb ischemia: a 3 year single center experience,
Keisuke Fukuda
    • Ovation Prime Stent Graft System can be used for challenging anatomy in EVAR cases, Koen Keirse
    • Ovation Prime Stent Graft System can be used for challenging anatomy in EVAR cases, Koen Keirse
    • Three cases confirming the appropriateness of “centralization of flow concept” in aortic dissection, Ivo Petrov
    • Artificial intelligence algorithms to quantify arterial calcification, Ahmed Aber
    • Carotid Artery Stenting: is it possible to reduce complications? Cinzia Moncalvo
    • Endovascular Repair of Mycotic Thoracic Aneurysm, Baris Ozdemir
    • Is there a place for the bioprosthesis Omniflow II in the treatment of aortic graft infection? Sebastien Deglise
    • Overcoming Difficult CTO increasing the applicability of Endovascular Intervention to patients with challenging Re-entry, Ahmed Tawfik
    ePosters presentations in the exhibition hall
    • Carotid artery stenting with cerebral embolic protection: a single-center initial experience, Pablo Nuñez
• Microcoil embolization for an acute bleed from ruptured middle rectal artery aneurysm,
Vivek Vohra
• Atherosclerotic plaque analysis in the lower limb may help predict outcome following
endovascular intervention, Vassilios Zymvragoudakis
• Use of drug-coated balloon angioplasty using the Invatec Admiral balloon as first line treatment for all femoropopliteal lesions: twelve month results, Koen Keirse
• Percutaneus exclusion of sbclavian artery aneurysm with endoprosthesis,
Cinzia Moncalvo
• Revascularization of the plantar arch: its impact on foot salvage in critical limb ischemia, Mosaad Soliman
• Interventional treatment of an intracranial left vertebral artery stenosis in the state of contralateral vertebral artery occlusion, Svetlin Tsonev
• Percutaneous exclusion of renal artery aneurysm with endoprosthesis, Cinzia Moncalvo
17.30   Awards ceremony & adjournment
MEET Official dinner • Radisson BLU Hotel
Monday June 8, 20.00 till midnight • Limited seats
Participation fee: 60 € VAT incl. per person (buffet dinner)
Dress code: casual chic